Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
LivaNova is a UK-based medical technology company dedicated to developing and distributing innovative therapies for patients globally. The company focuses on enhancing the quality of life for individuals with cardiovascular diseases and neurological disorders. Through its advanced products in cardiology, cardiac surgery, and neuromodulation, LivaNova is establishing itself as a leading provider in these specialized fields.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
LivaNova is scheduled to report its next quarterly earnings on 11/04/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
LivaNova last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 1.26 USD.
Across its last 3 earnings reports, LivaNova stock moved by ±7.6% on average the following day. The largest reaction was +15.1% on 05/06/2026; 2 of 3 reactions were positive.
LivaNova has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.